Atlas of Cancer Signaling Network: A Resource of Multi-Scale Biological Maps to Study Disease Mechanisms

[1]  Inna Kuperstein,et al.  Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. , 2018, Cancer cell.

[2]  Ryan Miller,et al.  WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research , 2017, Nucleic Acids Res..

[3]  T Avril,et al.  Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers , 2017, Oncogenesis.

[4]  Alfonso Valencia,et al.  A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer’s Disease, Glioblastoma and Lung cancer , 2017, Scientific Reports.

[5]  Chiara Riganti,et al.  PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy , 2017, Molecular Cancer.

[6]  Elisabeth Cardis,et al.  Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation , 2017, BMC Cancer.

[7]  Nils Blüthgen,et al.  Classification of gene signatures for their information value and functional redundancy , 2017, npj Systems Biology and Applications.

[8]  José Lages,et al.  Inferring hidden causal relations between pathway members using reduced Google matrix of directed biological networks , 2017, bioRxiv.

[9]  Inna Kuperstein,et al.  NaviCom: a web application to create interactive molecular network portraits using multi-level omics data , 2016, bioRxiv.

[10]  Piotr Gawron,et al.  MINERVA—a platform for visualization and curation of molecular interaction networks , 2016, npj Systems Biology and Applications.

[11]  Y. Pommier,et al.  Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors , 2016, Clinical Cancer Research.

[12]  Anaïs Baudot,et al.  Editorial: Direct and Inverse Comorbidities Between Complex Disorders , 2016, Front. Physiol..

[13]  E. Barillot,et al.  ROMA: Representation and Quantification of Module Activity from Target Expression Data , 2016, Front. Genet..

[14]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[15]  Dhruv Chauhan,et al.  A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation* , 2015, The Journal of Biological Chemistry.

[16]  Jing Chen,et al.  NDEx, the Network Data Exchange. , 2015, Cell systems.

[17]  Antonio Facchiano,et al.  Cancer Microenvironment and Endoplasmic Reticulum Stress Response , 2015, Mediators of inflammation.

[18]  Inna Kuperstein,et al.  Network-based approaches for drug response prediction and targeted therapy development in cancer. , 2015, Biochemical and biophysical research communications.

[19]  E. Barillot,et al.  Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps , 2015, Oncogenesis.

[20]  A. Zinovyev,et al.  Network biology elucidates metastatic colon cancer mechanisms , 2015, Cell cycle.

[21]  Inna Kuperstein,et al.  NaviCell Web Service for network-based data visualization , 2015, Nucleic Acids Res..

[22]  B. Hyman,et al.  Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation , 2015, Cell Death and Differentiation.

[23]  E. Barillot,et al.  The shortest path is not the one you know: application of biological network resources in precision oncology research. , 2015, Mutagenesis.

[24]  Ram Rup Sarkar,et al.  Comparison of human cell signaling pathway databases—evolution, drawbacks and challenges , 2015, Database J. Biol. Databases Curation.

[25]  Emmanuel Barillot,et al.  DeDaL: Cytoscape 3.0 app for producing and morphing data-driven and structure-driven network layouts , 2015, bioRxiv.

[26]  Alan Ashworth,et al.  Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors. , 2015, Annual review of medicine.

[27]  Inna Kuperstein,et al.  Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut , 2014, Nature Communications.

[28]  Tao Zeng,et al.  Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional profiling. , 2014, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[29]  Lei Huang,et al.  DrugComboRanker: drug combination discovery based on target network analysis , 2014, Bioinform..

[30]  H. Kitano,et al.  Toward an integrated software platform for systems pharmacology , 2013, Biopharmaceutics & drug disposition.

[31]  Laurence Calzone,et al.  Correction: Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision , 2013, PLoS Computational Biology.

[32]  Ney Lemke,et al.  Prediction of Oncogenic Interactions and Cancer-Related Signaling Networks Based on Network Topology , 2013, PloS one.

[33]  Samik Ghosh,et al.  A comprehensive map of the influenza A virus replication cycle , 2013, BMC Systems Biology.

[34]  Ioannis Xenarios,et al.  Efficient computation of minimal perturbation sets in gene regulatory networks , 2013, Front. Physiol..

[35]  Carlo Caltagirone,et al.  Inverse occurrence of cancer and Alzheimer disease , 2013, Neurology.

[36]  Samik Ghosh,et al.  Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map , 2013, Molecular Neurobiology.

[37]  E. Barillot,et al.  OCSANA: optimal combinations of interventions from network analysis , 2013, Bioinform..

[38]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[39]  Emmanuel Barillot,et al.  BiNoM 2.0, a Cytoscape plugin for accessing and analyzing pathways using standard systems biology formats , 2013, BMC Systems Biology.

[40]  Inna Kuperstein,et al.  NaviCell: a web-based environment for navigation, curation and maintenance of large molecular interaction maps , 2013, BMC Systems Biology.

[41]  Tzeng-Ji Chen,et al.  Does Alzheimer’s Disease Protect against Cancers? A Nationwide Population-Based Study , 2012, Neuroepidemiology.

[42]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[43]  Isaac Crespo,et al.  A Novel Network Integrating a miRNA-203/SNAI1 Feedback Loop which Regulates Epithelial to Mesenchymal Transition , 2012, PloS one.

[44]  A. Menssen,et al.  miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions , 2011, Cell cycle.

[45]  M. Nieto,et al.  The ins and outs of the epithelial to mesenchymal transition in health and disease. , 2011, Annual review of cell and developmental biology.

[46]  Robert Gentleman,et al.  An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription , 2011, Nucleic acids research.

[47]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[48]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[49]  Gary D. Bader,et al.  Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..

[50]  C. Ching,et al.  Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway , 2010, Laboratory Investigation.

[51]  H Snowden,et al.  AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K , 2010, Oncogene.

[52]  Umar Mahmood,et al.  Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment , 2010, Proceedings of the National Academy of Sciences.

[53]  Samik Ghosh,et al.  Erratum: The Systems Biology Graphical Notation , 2009, Nature Biotechnology.

[54]  A. Grossman,et al.  Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis , 2009, Expert opinion on therapeutic targets.

[55]  Nina M. Muñoz,et al.  TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. , 2009, Gastroenterology.

[56]  S. Artavanis-Tsakonas,et al.  Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine , 2009, Proceedings of the National Academy of Sciences.

[57]  Jean-Luc Coll,et al.  Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy , 2009, Clinical Cancer Research.

[58]  Emmanuel Barillot,et al.  BiNoM: a Cytoscape plugin for manipulating and analyzing biological networks , 2008, Bioinform..

[59]  O. Delattre,et al.  Mesenchymal stem cell features of Ewing tumors. , 2007, Cancer cell.

[60]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[61]  Yukiko Matsuoka,et al.  Using process diagrams for the graphical representation of biological networks , 2005, Nature Biotechnology.

[62]  Hiroaki Kitano,et al.  CellDesigner: a process diagram editor for gene-regulatory and biochemical networks , 2003 .

[63]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.